HUTCHMED (China) (HCM) Operating Income (2015 - 2021)
HUTCHMED (China) (HCM) posted quarterly Operating Income of $227.3 million for Q1 2021, up 60.7% year-over-year from $141.5 million in Q1 2020, and up 202.74% quarter-over-quarter from $75.1 million in Q2 2020.
HUTCHMED (China) (HCM) Operating Income (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Operating Income for 6 consecutive years, with $227.3 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Operating Income rose 60.7% year-over-year to $227.3 million; the TTM figure through Mar 2021 stood at $405.4 million (up 1089.18% YoY), while the FY2025 annual figure was -$39.2 million, up 10.4% from the prior year.
- Operating Income improved to $227.3 million in Q1 2021 per HCM's latest filing, from $75.1 million in the prior quarter.
- Across five years, Operating Income topped out at $227.3 million in Q1 2021 and bottomed at -$161.1 million in Q4 2018.
- Historically, Operating Income has averaged $18.6 million across 4 years, with a median of $14.8 million in 2018.
- Annual changes were most pronounced in 2019 — Operating Income sank 343.04% — and 2020, when it soared 292.37%.
- HUTCHMED (China)'s Operating Income stood at -$161.1 million in 2018, then jumped by 76.14% to -$38.4 million in 2019, then surged by 295.36% to $75.1 million in 2020, then soared by 202.74% to $227.3 million in 2021.
- Business Quant data shows HCM's Operating Income at $227.3 million in Q1 2021, $75.1 million in Q2 2020, and $141.5 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 227.32 Mn |
| Jun 30, 2020 | 75.09 Mn |
| Mar 31, 2020 | 141.45 Mn |
| Dec 31, 2019 | -38.43 Mn |
| Sep 30, 2019 | -35.94 Mn |
| Jun 30, 2019 | -108.06 Mn |
| Mar 31, 2019 | 36.05 Mn |
| Dec 31, 2018 | -161.11 Mn |
| Sep 30, 2018 | 14.79 Mn |
| Jun 30, 2018 | 78.70 Mn |
| Mar 31, 2018 | -25.02 Mn |
| Jun 30, 2016 | 90.74 Mn |
| Jun 30, 2015 | 74.57 Mn |